The simultaneous identification of carb-LL37 and both MPO and native LL37 in SLE-affected tissues corroborates the idea that neutrophilic inflammation typical of SLE favors carbamylation pathways [18]. The gene discussed is MPO; the disease is systemic lupus erythematosus.